Chenglan Li

发表

Targeting fungal virulence factor by small molecules: Structure-based discovery of novel secreted aspartic protease 2 (SAP2) inhibitors.

Shanchao Wu, Guoqiang Dong, C. Sheng, 2020, European journal of medicinal chemistry.

Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase (HDAC) Dual Inhibitors to Treat Azole-resistant Candidiasis.

C. Sheng, Na Liu, Zhuang Li, 2020, Journal of medicinal chemistry.

Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment.

Sai-Yang Zhang, Hong-min Liu, Jian Song, 2023, European journal of medicinal chemistry.

Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.

C. Sheng, Defeng Xu, Na Liu, 2021, European journal of medicinal chemistry.